BioSpace News Archive

Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor (“CGM”), together with BEAT®diabetes, a planned health subscription service designed to help people with Type 2 diabetes and prediabetes through personal

Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, today announced that its scientific cofounders, Christopher Natale , PhD, Vice President of Research at Linnaeus and Todd Ridky , MD, PhD

Medigate, a dedicated medical device security and asset management solution firm, today announced the Medigate Healthcare Protection Solution powered by Dell Technologies.

NextFlex, America’s Flexible Hybrid Electronics (FHE) Manufacturing Innovation Institute, announced today that it has secured seven years of government funding worth up to $154M in a cost-sharing agreement with the Air Force Research Laboratory (AFRL).

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company, announced today further details of its rights offering, which expired on June 8, 2020. Based on a preliminary tabulation by Broadridge Corporate Issuer Solutions, Inc. (the “Subscription Agent”), as of the Expiration Date, the Company received basic subscriptions and over-subscriptions for 7,962,587 u

Q-Centrix®, the largest exclusive provider of quality data management solutions to acute care hospitals and health systems, today announced the release of its Quality Data Index™ (QDI

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the pricing of its previously announced public offering for the offering of 2,175,000 shares of common stock of the Company at a price to the public of $11.40 per share

Wolters Kluwer, Health , a leading global provider of information and point of care solutions for the healthcare industry, has joined forces with the American Diabetes Association (ADA) and other collaborators to develop and virtually host its 80th Scientific Sessions: A Virtual Experience from June 12 through 16. The ADA’s annual, in-person meeting has been transformed into a fully digital experience leveraging com

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed a Memorandum Of Understanding with Cannomed Medical Cannabis Industries Ltd. (TASE: CNMD), to develop cannabis cultivars targeted to treat c

Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, and Alligator Bioscience AB (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,